Rhys Ponton

85 Park Road
Grafton, AUK 1023, New Zealand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

LSD microdosing in major depressive disorder: results from an open-label trial.

LSD microdosing in major depressive disorder: results from an open-label trial.

Journal: Neuropharmacology

Published: November 18, 2024

LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.

LSDDEP2: study protocol for a randomised, double-dummy, triple-blind, active placebo-controlled, parallel groups trial of LSD microdosing in patients with major depressive disorder.

Journal: Trials

Published: April 18, 2024

A Novel Stability Indicating High Performance Liquid Chromatography Method for Lysergic Acid Diethylamide Quantification: From Microdosing Applications to Broader Analytical Use.

A Novel Stability Indicating High Performance Liquid Chromatography Method for Lysergic Acid Diethylamide Quantification: From Microdosing Applications to Broader Analytical Use.

Journal: Journal of chromatographic science

Published: February 06, 2024

Psychedelic Drug Microdosing Practices: A Qualitative Online Exploration.

Psychedelic Drug Microdosing Practices: A Qualitative Online Exploration.

Journal: Journal of psychoactive drugs

Published: January 22, 2024

The New Zealand drug harms ranking study: A multi-criteria decision analysis.

The New Zealand drug harms ranking study: A multi-criteria decision analysis.

Journal: Journal of psychopharmacology (Oxford, England)

Published: June 24, 2023

An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).

An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).

Journal: Pilot and feasibility studies

Published: May 29, 2023

Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial.

Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial.

Journal: Biological psychiatry

Published: October 24, 2022

Correction to: MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers.

Correction to: MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers.

Journal: Trials

Published: May 11, 2021

A qualitative and quantitative account of patient's experiences of ketamine and its antidepressant properties.

A qualitative and quantitative account of patient's experiences of ketamine and its antidepressant properties.

Journal: Journal of psychopharmacology (Oxford, England)

Published: March 30, 2021

MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers.

MDLSD: study protocol for a randomised, double-masked, placebo-controlled trial of repeated microdoses of LSD in healthy volunteers.

Journal: Trials

Published: March 21, 2021

Why do pharmacists leave the profession? A mixed-method exploratory study.

Why do pharmacists leave the profession? A mixed-method exploratory study.

Journal: Pharmacy practice

Published: February 18, 2021

Pharmaceutical opioid changes risk overdose increase in New Zealand.

Pharmaceutical opioid changes risk overdose increase in New Zealand.

Journal: The New Zealand medical journal

Published: March 13, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026